Local biotech Illumina sees a slowdown in purchasing their large, full genome sequencing systems. However, with their substantial cash reserves the company can afford to play the long game.
http://www.xconomy.com/san-diego/2009/04/22/illumina-anticipates-purchasing-slowdown/
